Shamsah Amersi Reviews – Weight Loss Center

Clinic Information

Provider: Shamsah Amersi, MD
Practice: Amersi MD – Women’s Health & Hormone Specialist
Address: 2825 Santa Monica Blvd, Suite 320, Santa Monica, CA 90404, USA
Phone: (310) 264‑5600
Website: https://www.dramersi.com/

Overview

Dr. Amersi’s focus on providing high-quality women’s health care is based on evidence-based medical practices, advanced diagnostic techniques, and personalized treatment options. She provides OB-GYN services, understands how hormone imbalances can contribute to one’s health, supports women during menopause and PCOS, provides reproductive health care, and offers solutions for chronic illnesses. Her practice emphasizes the desire to assist women with their metabolic and hormonal health throughout the various stages of life—reproductive years to the perimenopausal stage, through all stages thereafter.

Medical Doctor

Dr. Shamsah Amersi, MD has over 20 years of hands-on experience working as a board-certified obstetrician-gynecologist and women’s health specialist. The University of California, San Francisco (UCSF), is where she graduated top 1% of her class and became a member of Alpha Omega Alpha, a national medical honor society.

Dr. Amersi is also board certified by the American Board of Obstetrics and Gynecology and is a member of the American College of Obstetrics and Gynecology. She has been named as one of the top doctors in the United States and California by several professional organizations and publications and serves on advisory committees supporting advancements in women’s hormone health.

GLP‑1 and Medical Weight Loss Programs

Dr. Amersi’s physician-supervised weight‑loss programs emphasize metabolic health/hormonal health as key contributors to actual long-term, sustainable weight loss as a result of weight loss programs aimed at women. There are many factors which may prevent women from losing weight, such as polycystic ovary system (PCOS), menopause, perimenopause, thyroid dysfunction, and insulin resistance.

The weight loss programs at Dr. Amersi’s office include medically- prescribed medications from her office, including:

• Semaglutide (e.g. Ozempic® or Wegovy®)
• Tirzepatide (e.g. Mounjaro® or Zepbound®)
• Metformin for insulin management.

The above medications help to suppress appetite, improve insulin resistance, assist the body in functioning properly metabolically, and create feelings of fullness. Any of these medications will be prescribed only in conjunction with guidance on both diet/ nutrition and physical fitness.

Dr. Amersi’s objective is to tailor an individualized program for each patient by evaluating their medical history, assuming relevant vital signs, body mass index (BMI), and analysis of their diet/ nutrition and exercise habits before evaluating the results of relevant lab tests.

Also, Dr. Amersi’s practice uses more gradual techniques, such as microdosing GLP-1 medications so that patients typically will not have to experience any significant side effects, and moderately enhancing metabolic rebalancing, ultimately achieving sustainable long-term results of weight loss.

Weight Loss Program Pricing

Pricing for weight-loss treatment at Dr. Amersi’s office is an individualized based on an evaluation for each patient rather than set pricing because each patient’s treatment regimen is highly variable due to their underlying health status and type of medication prescribed, dosage, length of time of the treatment regimen, lab testing required before and during treatment, and  potential follow-up visits.
Patients will contact our office to schedule an evaluation appointment, at which time a member of Dr. Amersi’s team will provide a thorough evaluation of the patient’s health status.

Patient Reviews

Patient feedback on sites like Google, Yelp and other directories mention how caring, attentive, and thorough she is in providing care, and many mention how thorough she is in the evaluations that she performs. Many patients specifically say that she takes time with them and listens intently when they are voicing concerns.

Site Link